A detailed history of Bruce G. Allen Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 213 shares of LLY stock, worth $163,532. This represents 0.15% of its overall portfolio holdings.

Number of Shares
213
Previous 307 30.62%
Holding current value
$163,532
Previous $278 Million 32.11%
% of portfolio
0.15%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$772.14 - $960.02 $72,581 - $90,241
-94 Reduced 30.62%
213 $189 Million
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $38,418 - $48,179
-53 Reduced 14.72%
307 $278 Million
Q1 2024

Apr 10, 2024

SELL
$592.2 - $792.28 $3,553 - $4,753
-6 Reduced 1.64%
360 $280 Million
Q4 2023

Jan 10, 2024

BUY
$525.19 - $619.13 $192,219 - $226,601
366 New
366 $213 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.